Terns Pharmaceuticals (TERN) Other Gross PP&E Adjustments (2020 - 2023)
Terns Pharmaceuticals (TERN) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$2.6 million as the latest value for Q3 2023.
- For the quarter ending Q3 2023, Other Gross PP&E Adjustments fell 28.7% year-over-year to -$2.6 million, compared with a TTM value of -$2.6 million through Dec 2023, down 1496.79%, and an annual FY2022 reading of $187000.0, down 89.99% over the prior year.
- Other Gross PP&E Adjustments was -$2.6 million for Q3 2023 at Terns Pharmaceuticals, up from -$3.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.9 million in Q4 2021 and bottomed at -$3.0 million in Q2 2023.
- Average Other Gross PP&E Adjustments over 4 years is -$1.3 million, with a median of -$1.6 million recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments surged 681.93% in 2021, then crashed 375.88% in 2022.
- Year by year, Other Gross PP&E Adjustments stood at -$321000.0 in 2020, then soared by 681.93% to $1.9 million in 2021, then tumbled by 89.99% to $187000.0 in 2022, then crashed by 1514.97% to -$2.6 million in 2023.
- Business Quant data shows Other Gross PP&E Adjustments for TERN at -$2.6 million in Q3 2023, -$3.0 million in Q2 2023, and -$2.5 million in Q1 2023.